Unknown

Dataset Information

0

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?

ABSTRACT: Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we tested the use of five experimental animals (mice, hamsters, rabbits, ferrets, and chickens) for RBD immunogenicity assessments. The humoral immune response was evaluated by ELISA and virus-neutralization assays. The data obtained show hamsters to be the least suitable candidates for RBD immunogenicity testing and, hence, assessing the protective efficacy of RBD-based vaccines.

SUBMITTER: Merkuleva IA 

PROVIDER: S-EPMC9146860 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we tested the use of five experimental animals (mice, hamsters, rabbits, ferrets, and chickens) for RBD immunogenicity assessments. The humoral immune response was evaluated by ELISA and virus-neutralization assays. The data obtained show hamsters to be the  ...[more]

Similar Datasets

Unknown Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™.
| S-EPMC10028357 | biostudies-literature
Unknown RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates.
| S-EPMC8423076 | biostudies-literature
Unknown Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workers.
| S-EPMC10760357 | biostudies-literature
Unknown Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants.
| S-EPMC10067881 | biostudies-literature
Unknown [Anti-COVID-19 RNA vaccines].
| S-EPMC7796673 | biostudies-literature
Unknown Scientific rationale for developing potent RBD-based vaccines targeting COVID-19.
| S-EPMC8553742 | biostudies-literature
Unknown COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing.
| S-EPMC9029796 | biostudies-literature
Unknown Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19.
| S-EPMC8282488 | biostudies-literature
Unknown Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals.
| S-EPMC8425430 | biostudies-literature
Unknown Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines.
| S-EPMC6789684 | biostudies-literature